Clinical Trial Update: Study Evaluating PPM-204 In Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating PPM-204 in Type 2 diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PPM-204

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Diabetes Mellitus | Phase 2 | Status: TERMINATED